Literature DB >> 21885542

Pulmonary resection after lung transplantation in cystic fibrosis patients.

Rédha Souilamas1, Mauricio Saueressig, Véronique Boussaud, Catherine Amrein, Romain Guillemain, Joshua Sonett.   

Abstract

Pulmonary resection after lung transplantation in end-stage cystic fibrosis presents unique challenges, and scant literature exists to guide physicians. We retrospectively reviewed 78 transplants for cystic fibrosis performed between 2003 and 2008. Fourteen patients underwent posttransplantation pulmonary resection. We analyzed the indications, surgical procedures, outcomes, and survival. Three pneumonectomies, 4 lobectomies, and 11 wedge resections were carried out. We identified 2 groups based on indication: a diagnostic group, and a therapeutic group of patients in whom the indications were septic native lung in 2, allograft infection in 2, lobar torsion in 2, pulmonary infarction in 2, and size mismatch in 4. The mean intensive care unit and hospital stays were 29 and 50 days, respectively. Four (28.57%) patients died during follow-up, including 2 who underwent pneumonectomy; 10 (71.43%) are still alive. Survival was 43.43 ± 8.06 months, and it was not significantly different from that in cystic fibrosis patients who had lung transplantation without pulmonary resection. Pulmonary resection following lung transplantation in cystic fibrosis patients showed acceptable survival and surgical risk, but metachronous pneumonectomy was associated with higher mortality.

Entities:  

Mesh:

Year:  2011        PMID: 21885542     DOI: 10.1177/0218492311409242

Source DB:  PubMed          Journal:  Asian Cardiovasc Thorac Ann        ISSN: 0218-4923


  1 in total

1.  A quality improvement program to reduce the time on the lung transplant waiting list at the Nantes University Hospital.

Authors:  Isabelle Danner-Boucher; Véronique Loppinet; Aurore Boxus; Claire Dary; Anne Brigitte Lambert; Marine Prieur; Céline Vallet; Adrien Tissot
Journal:  Orphanet J Rare Dis       Date:  2018-02-08       Impact factor: 4.123

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.